SuperGen Withdraws Drug Application
246516
SuperGen Inc. on Monday said it has  withdrawn an application to market its pancreatic cancer drug  in the United States due to insufficient data, casting a cloud  on the drug's future in the world's biggest market and sending  the company's shares down as much as 16 percent.
374438
Vioxx, the blockbuster arthritis drug heavily promoted on TV and taken by some 2 million people worldwide, was pulled from the market by its maker yesterday after a study found it doubled the risk of heart attacks and strokes.
114882
Under pressure for more data on the long-term safety effects of its Intrinsa testosterone patch, Procter &amp; Gamble Co. has withdrawn its application to the US Food and Drug Administration to market the patch.
249030
Sanofi-Aventis SA is withdrawing its application to sell obesity drug rimonabant -- its biggest new drug hope -- in the United States, the French drugmaker said on Friday.
53283
BEIJING -- China's drug watchdog announced Saturday it has suspended the sale of a drug used to treat acute leukemia and rheumatoid arthritis in the latest move to hit the country's scandal-ridden drug industry.
199689
Shares of SuperGen Inc.  dropped 17 percent before the bell on Monday after the company said it withdrew an application to market its pancreatic cancer treatment in the United States due to insufficient data.
106113
Shares in AstraZeneca tumbled today after a key drug it has developed in the fight against strokes was provisionally rejected by US regulators.
79138
Sanofi-Aventis has withdrawn its   marketing application for its Multaq heart arrhythmia treatment   in the European Union, the world's third-largest drugmaker said   on Thursday.
232138
MGI Pharma Inc. MOGN.O will spend up  to $85 million for a stake in SuperGen Inc. SUPG.O and global  rights to develop and sell SuperGen's experimental drug for an  often-fatal cancer of the bone marrow, the companies said on  Wednesday.
367445
The Swiss pharmaceutical group Novartis withdrew on Tuesday an application for EU approval of a new arthritis drug called Prexige to await a review of such treatments next year.
290376
A popular painkiller is being withdrawn from the market over concerns about links with overdoses.
533556
Shares of SuperGen Inc. SUPG.O  dropped 17 percent before the bell on Monday after the company  said it withdrew an application to market its pancreatic cancer  treatment in the United States due to insufficient data.
619726
AstraZeneca, the Anglo-Swedish pharmaceutical group, suffered another setback when it suspended marketing of Iressa, a lung cancer drug launched this year.
572824
AstraZeneca PLC said Tuesday that it is withdrawing its application to market its lung cancer drug Iressa in Europe, following findings that the drug failed to prolong survival when compared with a sugar pill.
579429
Novartis AG, Switzerland s largest drugmaker, withdrew an application for European Union approval of its experimental Prexige, a painkiller similar to Merck & Co.
109692
Contrary to what the product promises to do, the latest Viagra campaign has gone limp. According to US media reports, the US-based Food and Drug Administration has ordered drug major Pfizer to stop running
98284
Some Parkinson's patients say drug developer Amgen robbed them of their only hope by ordering all patients off an experimental drug.